Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPPL1 | O15357 | 11/20 | 0.61 |
| ▸ | INPP5A | Q14642 | 6/20 | 0.61 |
| ▸ | INPP5B | P32019 | 2/20 | 0.61 |
| ▸ | SRC | P12931 | 5/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | AKT1 | P31749 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29434062 | 0.90 | INPPL1 (0.52) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL1043483 | 0.88 | INPPL1 (0.50) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL27780600 | 0.88 | ALDH1A1 (0.53) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL2573126 | 0.87 | INPPL1 (0.70) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL3693358 | 0.87 | KDM4E (0.56) | INPPL1INPP5AINPP5BSRCKDM4E | |
| Hydrochloric Acid SCHEMBL28439740 | 0.86 | KDM4E (0.55) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL28011514 | 0.85 | INPPL1 (0.52) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL9308174 | 0.84 | INPPL1 (0.55) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL3873601 | 0.84 | INPPL1 (0.50) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL6246385 | 0.84 | INPPL1 (0.46) | INPPL1INPP5AINPP5BSRCKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1989005794-A1 | NOVEL ANTIARRHYTHMIC AGENTS I | Aktiebolaget Hässle (SE) | 1989-06-29 | — | — | WO | claimed |
| EP-0322390-A2 | Novel antiarrhythmic agents I | Aktiebolaget Hässle (SE) | 1989-06-28 | — | — | EP | claimed |
| US-12528915-B2 | Polycarbonate resin composition | IDEMITSU KOSAN CO.,LTD. (JP) | 2026-01-20 | — | — | US | disclosed |
| US-20250354010-A1 | MOLDED BODY INCLUDING POLYCARBONATE-BASED RESIN COMPOSITION | IDEMITSU KOSAN CO.,LTD. (JP) | 2025-11-20 | — | — | US | disclosed |
| US-12428557-B2 | Molded body including polycarbonate-based resin composition | IDEMITSU KOSAN CO., LTD. (JP) | 2025-09-30 | — | — | US | disclosed |
| US-20220363893-A1 | MOLDED BODY INCLUDING POLYCARBONATE-BASED RESIN COMPOSITION | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-11-17 | — | — | US | disclosed |
| US-20220363839-A1 | POLYCARBONATE RESIN COMPOSITION | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-11-17 | — | — | US | disclosed |
| US-11352478-B2 | Flame-retardant polycarbonate-based resin composition and molded product thereof | IDEMITSU KOSAN CO., LTD. (JP) | 2022-06-07 | — | — | US | disclosed |
| EP-3995540-A1 | POLYCARBONATE RESIN COMPOSITION | Idemitsu Kosan Co.,Ltd. (JP) | 2022-05-11 | — | — | EP | disclosed |
| EP-3995527-A1 | MOLDED BODY INCLUDING POLYCARBONATE-BASED RESIN COMPOSITION | Idemitsu Kosan Co.,Ltd. (JP) | 2022-05-11 | — | — | EP | disclosed |
| EP-3541776-B1 | NOVEL PROCESS FOR THE MANUFACTURE OF GAMMA, DELTA-UNSATURATED KETONES | DSM IP ASSETS BV (NL) | 2020-12-23 | — | — | EP | disclosed |
| EP-0322390-B1 | NOVEL ANTIARRHYTHMIC AGENTS I | Aktiebolaget Hässle (SE) | 1992-11-11 | — | — | EP | disclosed |
| US-5155133-A | Antiarrhythmic compounds and pharmaceutical compositions and methods thereof | AKTIEBOLAGET HASSLE (SE) | 1992-10-13 | — | — | US | disclosed |
| WO-1989005794-A1 | NOVEL ANTIARRHYTHMIC AGENTS I | Aktiebolaget Hässle (SE) | 1989-06-29 | — | — | WO | disclosed |
| EP-0322390-A2 | Novel antiarrhythmic agents I | Aktiebolaget Hässle (SE) | 1989-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528915-B2 | Polycarbonate resin composition | PSMB2, PSMA1, PSMB1 | INPPL1 4074/4885INPP5A 4507/4885INPP5B 4575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.